Tymoszuk et al. recently demonstrated that iron overload directly inhibited CD8+ T cell activation and that the therapeutic effect of the anti-PD-L1 antibody was diminished in C57BL/6J female mice that were implanted with E0771 mammary carcinoma [34]. The gene discussed is CD8A; the disease is breast carcinoma.